CBRE real estate consultancy company advised the relocation process for the pharmaceutical company Novo Nordisk, who leased an area of 580 sqm offices in the Tiriac Tower building, located in Victoriei Square. The transaction was signed in March.

“The construction of Tiriac Tower carries on uninterruptedly and we have recently completed the superstructure of the building, respecting the time and safety conditions agreed. Tiriac Tower will be the most stylish and safe building in the central area of the Capital city, being also the only building in the Victoriei Square area that offers 1,200 sqm of terraces and patios, a benefit for which companies have shown high interest in the last two months”, revealed Raăzvan Enache, Managing Director of Tiriac Imobiliare.

The Danish company Novo Nordisk, worldwide known for its insulin production, will take up the 9th floor of the Tiriac Tower building, consisting of about 580 sqm of offices and two terraces with an area of over 120 sqm, according to CBRE, who advised the transaction.

Tiriac Tower is the newest building in Victoriei Square, the iconic business area of the Capital city. The building has a leasable area of approximately 16,500 sqm, comprising 12 floors and will accommodate occupiers in the fields of law, strategic consulting, insurance, engineering and the pharmaceutical industry. CBRE has advised the lease of a total volume of 30 percent of the entire building so far.